PATISIRAN vs PEGFILGRASTIM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PATISIRAN vs PEGFILGRASTIM: Safety Overview
| Metric | PATISIRAN | PEGFILGRASTIM |
|---|---|---|
| Total FAERS Reports | 2,708 | 80,974 |
| Deaths Reported | 384 | 2,367 |
| Death Rate | 14.2% | 2.9% |
| Hospitalizations | 1,050 | 7,050 |
| Average Patient Age | 65.6 yrs | 61.2 yrs |
| % Female Patients | 34.2% | 66.3% |
| FDA Approval Date | Aug 10, 2018 | N/A |
| Manufacturer | Alnylam Pharmaceuticals, Inc. | Sandoz Inc |
| Route | INTRAVENOUS | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |